Contraindications to Warfarin
- Bleeding diathesis
- Previous GI bleeding
- Intracranial hemorrhage/aneurysm/retinopathy
- Severe hypertension
- Bacterial endocarditis
- Alcoholism
- Unsupervised dementia
- Frequent falls
- First trimester of pregnancy
Other Risk Factors for Adverse Events on Warfarin
- Elderly
- Polypharmacy
- Renal impairment
- Hepatic impairment
- Pregnancy
- Recent surgery/trauma/heart failure/thyrotoxicosis
Advice on Warfarin
Nature of Warfarin
- Warfarin is an oral anticoagulant that thins the blood to prevent clot formation in the legs and other parts of the body.
Benefits
- Recommended for the prevention of recurrent DVT due to the risk of potentially life-threatening pulmonary embolism (PE).
Risks
- Bleeding
- Major bleeding < 2% per year.
- INR is a major determinant, especially if > 3.
- Bleeding is most likely in the first 3 months of therapy.
- Risk in Pregnancy (Teratogenicity)
- Recognized teratogen (Category D) – crosses placenta.
- Contraindicated in pregnancy.
- First trimester: Fetal warfarin syndrome (FWS)/warfarin embryopathy (bone stippling & nasal hypoplasia).
- Third trimester: Perinatal fetal or placental hemorrhage.
- Infrequent Idiosyncratic Reactions (Type B)
- Rashes
- Purple discoloration of toes
- Skin necrosis
- Fever
- Cholesterol embolism
- Allergic reactions
- Alopecia
- Nausea & vomiting
- Hepatic dysfunction
- Diarrhea
Interactions
- Warfarin is metabolized by liver enzymes (cytochrome P450). Many medications and herbal preparations can affect its absorption, binding, and metabolism.
- Drugs that Inhibit Cytochrome P450 Enzymes (Increased Effect)
- Antibiotics: erythromycin, ciprofloxacin, co-trimoxazole, metronidazole, fluconazole.
- Drugs that Induce Hepatic Enzymes (Reduced Effect)
- Antibiotics: rifampicin.
- Antiepileptics: carbamazepine, phenytoin.
- St. John’s Wort
- Alcohol
- Antiplatelet Drugs (Additive Effect – Avoid)
- Aspirin
- Clopidogrel
- Dipyridamole
Monitoring
- Controlled Initiation with Heparin
- Use heparin to prevent procoagulation-mediated thrombosis.
- Daily monitoring until a stable therapeutic dose is established.
- Regular Monitoring of INR
- Regular blood tests (weekly for the first month; monthly thereafter).
- Aim for INR 2-3; mechanical heart valves require INR 2.5-3.5.
- Patients to call for results within 24 hours and adjust dose if necessary.
- Patient Education (Anticoagulant Book)
- Dosing
- Same brand of tablets.
- Same time every day.
- Emphasize adherence.
- Lifestyle
- Dietary Consistency:
- Maintain a consistent intake of vitamin K, which is found in green leafy vegetables (e.g., spinach, broccoli, kale).
- Avoid sudden changes in the amount of vitamin K in your diet, as this can affect your INR.
- Alcohol:
- Limit alcohol intake to no more than 1-2 standard drinks per day, as excessive alcohol can increase bleeding risk.
- Exercise:
- Engage in regular physical activity
- avoid contact sports or activities that increase the risk of injury
- Side Effects
- Heightened awareness of signs of bleeding: headache, abdominal pain, melena, hematuria, nosebleeds.
- Pregnancy
- Use barrier contraception.
- Inform doctor if pregnant.
- Interactions
- Avoid aspirin.
- Inform pharmacist and doctor about any new medications (prescription, herbal, vitamin supplements).
- INR tested after 4 days of new drug and at the end of the course.
- Inform Healthcare Providers
- Inform physiotherapist, podiatrist, chiropractor, dentist.
- Surgery
- Stop warfarin 4-5 days prior. Substitute with unfractionated or low-molecular-weight heparin subcutaneously.
- Medical Alert:
- Consider wearing a medical alert bracelet indicating you are on warfarin.
- Travel:
- If traveling, ensure you have enough medication and arrange for INR testing if you will be away for an extended period.
Complications to Watch Out For
- Signs of Bleeding:
- Unusual bruising or bleeding (e.g., gums, nosebleeds, heavier menstrual periods).
- Dark, tarry stools or blood in your urine.
- Severe headaches, dizziness, or weakness (potential signs of internal bleeding).
- Prolonged bleeding from cuts or injuries.
- Signs of Blood Clots:
- Swelling, pain, or tenderness in your legs (potential DVT).
- Sudden shortness of breath, chest pain, or coughing up blood (potential PE).
Warfarin Reversal
No Bleeding
- INR 5 to 9
- Cease warfarin therapy; consider reasons for elevated INR and patient-specific factors.
- Vitamin K:
- Phytomenadione 1 to 2 mg orally OR
- Phytomenadione 0.5 to 1 mg IV
- INR 9 or Higher
- Low risk of bleeding: cease warfarin therapy and give vitamin K:
- Phytomenadione 2.5 to 5 mg orally OR
- Phytomenadione 1 mg IV
- High risk of bleeding: cease warfarin therapy and give vitamin K:
- Prothrombinex -VF 25 to 50 units/kg IV PLUS
- Fresh frozen plasma 150 to 300 mL.
Bleeding
- Clinically significant bleeding with warfarin-induced coagulopathy:
- Phytomenadione 5 to 10 mg IV PLUS
- Prothrombinex -VF 25 to 50 units/kg IV PLUS
- Fresh frozen plasma 150 to 300 mL (if available).
Related